Hospital Acquired Infection Control Market Analysis Report By Type, By End User, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global hospital acquired infection control market was prized by USD 5.5 billion in 2020. It is estimated to witness 4.9% CAGR from 2021 to 2028.

Drivers

A number of important driving factors of the market are encouraging government proposals to endorse infection control systems, the occurrence of transferable sicknesses in healthcare amenities, the necessity to restrain cross infectivity, and rising alertness, related to Hospital Acquired Infections (HAIs).

The setting up of infectivity avoidance procedures and standards at nationwide, provincial, and hospital levels plus the increasing implementation of monitoring solutions are, additionally, encouraging the enlargement of the hospital acquired infection control market.

Furthermore, the pandemic stimulated the improvement of innovative technology as well as the solutions, to detect and control the increase of infectivity in healthcare amenities. During the period of Covid-19, the National Human Genome Research Institute (NHGRI) built up an innovative means to stop the increase of Hospital Acquired Infections (HAIs), in January 2021. These kinds of improvements are expected to stimulate demand for the infection control products in hospitals, during the forecast period.

Effect of Covid-19

The eruption of Covid-19 pandemic held a remarkable effect on the market for hospital acquired infection control. It stimulated the demand for consumables particularly, gloves, PPE kits, hand sanitizers, masks, and disinfectants. Augmented demand for infection control services and products was witnessed, throughout the preceding year. For example, the Met all Zug Group stated the unfavorable effect of the Covid-19 pandemic on its general transactions, in August 2020. Yet, the company told an increasing move in its infection control business division.

COVID19 Hospital Acquired Infection Control market impact: ~3.0% increase in demand

Type Insight

The consumables section held the major, 47.0% revenue share and led the hospital acquired infection control market, in 2020. This is because of the growing financial support for R&D by the companies, together with excessive use of the consumables in ambulatory centers and hospitals. The Covid-19 pandemic performed like the major provider for the leading share, held by the consumables section.

The services section is expected to record the maximum 5.2% CAGR, during the forecast period. These comprise software designed for checking compliance, planning plus execution of infection control agendas, disinfection service plus others. As a result of the encouraging strategies, put up by the government establishments as well as rising alertness stages, the demand for the services is likely to boost, during the near future.

End Use Insight

The hospitals and Intensive Care Units (ICUs) section held the major, 46.0% revenue share and led the hospital acquired infection (HAI) control market, in 2020. Consistent with an investigation carried out, in Iran, by the Kerman University of Medical Sciences, for the duration of Covid-19 pandemic, the occurrence of hospital acquired infections (HAIs) was extreme because of the augmented admissions, extended period of hospital stays, and the execution of actions. Although, as contrast to other wards, the figure of patients admitted to ICUs was fewer.

The ambulatory surgical and diagnostic centers section is likely to observe the highest 5.2% CAGR, during the forecast period. The specially made products presented by the contestants, particular to ambulatory surgical centers, are projected to increase the implementation of hospital acquired infection control products, in the near future. Such as, STERIS supply a variety of steam sterilizers, intended for a category of small places comprising ambulatory surgery centers, in addition to outpost sites.

Regional Insight

In 2020, North America held the major, above 34.0% revenue share and led the global HAI control market. The greater share can be credited to the rising alertness regarding the hospital acquired infections with in this region, existence of crucial companies and the plans executed by them in private and public sector.

The market in Asia Pacific is projected to observe the highest 5.7% CAGR, during the subsequently few years. This is because of the increasing commonness of hospital acquired infections, in addition to increasing healthcare infrastructure in middle and low income nations.

As contrast to high income nations, the rate of recurrence of ICU-acquired disease is 2 to 3 times greater in middle and low income nations; this is said by the World Health Organization (WHO). While, as equated to the U.S., the apparatus linked contaminations are almost 13 times greater.

In developing nations, the infants are at a greater risk of constricting healthcare linked infections in comparison with the high-income nations. The World Health Organization (WHO) measures the illness rates at nearly 3 to 20 times greater. This is likely to stimulate the expansion of the market, particularly within Asia Pacific, Latin America, as well as Middle East & Africa regions.

Companies

The characteristic of the global market for hospital acquired infection control is aggressive. The companies are taking on tactical programs for example, intensification of R&D activities along with delivery system, customer acquirement, and intentional joint ventures. Moreover, the companies are in process of providing funds for latest technologies and diversification of product range.

Some of the companies for hospital acquired infection control market are:

    • Belimed AG
    • ASP (Advanced Sterilization Products)
    • 3M
    • Getinge AB
    • Olympus Corporation
    • KCWW (Kimberly-Clark Worldwide, Inc.)
    • Ecolab
    • STERIS
    • Xenex Disinfection Services Inc.
    • BD

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this report, Million Insights has segmented the global hospital acquired infection control market report on the basis of type, end user, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)
    • Equipment
        • Sterilization Equipment
            • Heat Sterilization Equipment
                • Moist Heat Sterilization
                • Dry Heat Sterilization
            • Low Temperature Sterilization
            • Radiation Sterilization
            • Others
        • Disinfection Equipment
            • Washer Disinfector
            • Flusher Disinfector
            • Endoscopic Reprocessor Systems
    • Services
    • Consumables
        • Disinfectants
        • Sterilization Consumables
        • Others (Waste Disposal, PPE)

• End-user Outlook (Revenue, USD Million, 2016 - 2028)
    • Hospitals and Intensive Care Units (ICUs)
    • Ambulatory Surgical and Diagnostic Centers'
    • Others (Nursing Homes and Maternity Centers)

• Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Australia
    • Latin America
        • Brazil
        • Mexico
        • Argentina
    • MEA
        • South Africa
        • Saudi Arabia
        • UAE